2 Healthcare Stocks That Could Make You Richer

09:53am, Wednesday, 14'th Jun 2023
Medtronic is getting a makeover as it increasingly focuses on high-growth opportunities. Merck is developing additional medicines to decrease reliance on its crown jewel.
Drugmaker Merck & Co. MRK, +0.12% on Tuesday said that a U.S. district court had validated U.S. patent protection for its neuromuscular drug Bridion through “at least January 2026.” The announceme
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Merck & Co., Inc. (NYSE:MRK ) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023 7:00 PM ET Company Participants Caroline Litchfield - Chief Financial Officer Conference Call Partici
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present Data for Efinopegdutide (MK-6024), an Investigational GLP-1/Glucagon Receptor Co-agonist at EASL 2023.
Novocure sells a cancer treatment that is already popular among patients with brain cancer. Brain cancer is relatively rare, so investors are hoping an expansion to the larger lung cancer indication w
The 4-factor dividend growth portfolio is a strategy that leverages the stock selection process of Schwab U.S. Dividend Equity ETF™, with a few minor twists. The portfolio gained 1.84% in May, outpe
The Dow Jones Industrial Average ticked up about 0.1%, or 44 points, on below-average volume as investors await next week's inflation reading and an interest rate decision from the Federal Reserve.
FDA accepts Merck's (MRK) supplemental biologics license application for Keytruda plus chemotherapy for the treatment of patients with first-line advanced or metastatic biliary tract cancer.
The Biden administration on Thursday indicated no pause in its timeline for Medicare drug price negotiations in the wake of a legal challenge from pharmaceutical giant Merck MRK, +1.57%.
Despite muted trading volumes, the Dow Jones Industrial Average rose 0.5%, or 169 points, as investors digested data that suggested rising interest rates may finally be hitting the labor market.
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The 3 Best Defensive Stocks to Buy in June 2023

08:10pm, Wednesday, 07'th Jun 2023
While Wall Street appears pleased with the latest hotter-than-expected jobs report, investors might benefit from the best defensive stocks to buy. At first, such a notion seems overly pessimistic give
Merck (MRK) files a lawsuit against claiming that the federal government is violating the Constitution by forcing drugmakers to negotiate prices at below market rates.

US Equities Mixed at Midday as Energy Stocks Gain

12:40pm, Wednesday, 07'th Jun 2023
U.S. equities were mixed at midday on Wednesday, June 7, 2023, as tech and communication stocks weighed on the major indexes.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE